Christopher Richard Anzalone, CEO: Arrowhead Pharmaceuticals ARWR Sell · Filed 24/12/23

Trade details

Type: Insider sale
Amount: $246,109.17
Shares · price: 12,563 sh · $19.59 a share
Held after: 3,775,772 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Christopher Richard AnzaloneCEO
Trade date: 24/12/23
Filed: 24/12/23
Days to filing: 0 days

Sold 0.3% of holdings

Share of holding sold: 0.3%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/11/23~25/01/22

Christopher Richard Anzalone's recent trades

Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$488.6K
7,416 sh
$488.6K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$383.1K
5,771 sh
$383.1K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$871.7K
13,187 sh
$871.7K
Filed 01/02
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$2.4M
35,181 sh
$2.4M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$1.1M
16,545 sh
$1.1M
Filed 25/12/30
Traded 25/12/29